Social and Emotional Impairment in Children and Adolescents with ADHD and the Impact on Quality of Life

Journal of Adolescent Health

Volumn 46, Issue 3, 2010, Pages 209-217

  Wehmeier, Peter M ^a   Schacht, Alexander ^a   Barkley, Russell A ^b,c  

^a LILLY DEUTSCHLAND GMBH   (Germany)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

ADHD; Emotional impairment; Quality of life; Social impairment

Indexed keywords

METHYLPHENIDATE;

ADOLESCENCE; ADULTHOOD; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; AUTOREGULATION; BEHAVIOR DISORDER; BEHAVIOR MODIFICATION; CHILD PARENT RELATION; COGNITION; DEPRESSION; EMOTIONAL DISORDER; FAMILY; HUMAN; PARENTAL STRESS; PEER GROUP; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUALITY; SOCIAL DISABILITY; SOCIAL ENVIRONMENT; SOCIAL PSYCHOLOGY; WELLBEING; WORKING MEMORY;

ADOLESCENT; AFFECTIVE SYMPTOMS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; HUMANS; INTERPERSONAL RELATIONS; MODELS, THEORETICAL; QUALITY OF LIFE;

EID: 76349118545     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2009.09.009     Document Type: Review

References (124)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision (DSM-IV-TR) (2000), American Psychiatric Association, Washington, DC
2. Faraone S.V., Sergeant J., Gillberg C., et al. The worldwide prevalence of ADHD: Is it an American condition?. World Psychiatry 2 (2003) 104-112
3. Polanczyk G., de Lima M.S., Horta B.L., et al. The worldwide prevalence of ADHD: A systematic review and metaregression analysis. Am J Psychiatry 164 (2007) 942-948
4. Biederman J., and Faraone S.V. Attention-deficit hyperactivity disorder. Lancet 366 (2005) 237-248
5. Teicher M.H., Andersen S.L., Navalta C.P., et al. Neuropsychiatric disorders of childhood and adolescence. In: Yudofsky S.C., and Hales R.E. (Eds). The American Psychiatric Publishing Textbook of Neuropsychiatry and Clinical Neurosciences (2002), American Psychiatric Publishing, Washington, DC 1069-1119
6. World Health Organization (WHO). The ICD-10 Classification of Mental and Behavioural Disorders. Clinical descriptions and diagnostic guidelines (1992), World Health Organization, Geneva
7. Goos L.M., Crosbie J., Payne S., et al. Validation and extension of the endophenotype model in ADHD patterns of inheritance in a family study of inhibitory control. Am J Psychiatry 166 (2009) 711-717
8. Barkley R.A., Murphy K.R., and Fischer M. ADHD in Adults: What the Science Says (2008), Guilford Publications, New York, NY
9. Wender P.H. Attention-Deficit Hyperactivity Disorder in Adults (1998), Oxford University Press, Oxford, UK
10. Wender P.H., Wolf L.E., and Wasserstein J. Adults with ADHD: An overview. Ann N Y Acad Sci 931 (2001) 1-16
11. Kessler R.C., Adler L.A., Barkley R., et al. Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood. Results from the National Comorbidity Survey Replication. Biol Psychiatry 57 (2005) 1442-1451
12. Wolraich M.L., Wibbelsman C.J., Brown T.E., et al. Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications. Pediatrics 115 (2005) 1734-1746
13. Barkley R.A. Attention-Deficit/Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. 3rd edition (2006), Guilford Press, New York, NY
14. Thompson M.J., Brooke X.M., West C.A., et al. Profiles, co-morbidity and their relationship to treatment of 191 children with AD/HD and their families. Eur Child Adolesc Psychiatry 13 (2004) 234-242
15. Swanson J.M. Role of executive function in ADHD. J Clin Psychiatry 64 Suppl 14 (2003) 35-39
16. Perwien A.R., Faries D.E., Kratochvil C.J., et al. Improvement in health-related quality of life in children with ADHD: An analysis of placebo controlled studies of atomoxetine. J Dev Behav Pediatr 25 (2004) 264-271
17. Escobar R., Soutullo C.A., Hervas A., et al. Worse quality of life for children with newly diagnosed attention-deficit/hyperactivity disorder, compared with asthmatic and healthy children. Pediatrics 116 (2005) e364-e369
18. Perwien A.R., Kratochvil C.J., Faries D.E., et al. Atomoxetine treatment in children and adolescents with attention-deficit hyperactivity disorder: What are the long-term health-related quality-of-life outcomes?. J Child Adolesc Psychopharmacol 16 (2006) 713-724
19. Barkley R.A. Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. J Clin Psychiatry 63 Suppl 12 (2002) 10-15
20. Nijmeijer J.S., Minderaa R.B., Buitelaar J.K., et al. Attention-deficit/hyperactivity disorder and social dysfunctioning. Clin Psychol Rev 28 (2008) 692-708
21. Escobar R., Hervas A., Soutullo C.A., et al. Attention-deficit/hyperactivity disorder: Burden of the disease according to subtypes in recently diagnosed children [Editorial]. Actas Esp Psiquiatr 36 (2008) 285-294
22. Brook U., and Boaz M. Attention deficit and hyperactivity disorder (ADHD) and learning disabilities (LD): Adolescents perspective. Patient Educ Couns 58 (2005) 187-191
23. Karande S., Bhosrekar K., Kulkarni M., et al. Health-related quality of life of children with newly diagnosed specific learning disability. J Trop Pediatr 55 (2009) 160-169
24. Varni J.W., and Burwinkle T.M. The PedsQL as a patient-reported outcome in children and adolescents with Attention-Deficit/Hyperactivity Disorder: A population-based study. Health Qual Life Outcomes 4 (2006) 26
25. Johnston C., and Mash E.J. Families of children with attention-deficit/hyperactivity disorder: Review and recommendations for future research. Clin Child Fam Psychol Rev 4 (2001) 183-207
26. Sawyer M.G., Whaites L., Rey J.M., et al. Health-related quality of life of children and adolescents with mental disorders. J Am Acad Child Adolesc Psychiatry 41 (2002) 530-537
27. Klassen A.F., Miller A., and Fine S. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Pediatrics 114 (2004) e541-e547
28. Matza L.S., Rentz A.M., Secnik K., et al. The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder. J Dev Behav Pediatr 25 (2004) 166-174
29. Riley A.W., Spiel G., Coghill D., et al. Factors related to Health-Related Quality of Life (HRQoL) among children with ADHD in Europe at entry into treatment. Eur Child Adolesc Psychiatry 15 Suppl 1 (2006) i38-i45
30. Strine T.W., Lesesne C.A., Okoro C.A., et al. Emotional and behavioral difficulties and impairments in everyday functioning among children with a history of attention-deficit/hyperactivity disorder. Prev Chronic Dis 3 (2006) A52
31. Harpin V.A. The effect of ADHD on the life of an individual, their family, and community from preschool to adult life. Arch Dis Child 90 Suppl 1 (2005) i2-i7
32. Thorell L.B., and Rydell A.M. Behaviour problems and social competence deficits associated with symptoms of attention-deficit/hyperactivity disorder: Effects of age and gender. Child Care Health Dev 34 (2008) 584-595
33. Coghill D., Soutullo C., d'Aubuisson C., et al. Impact of attention-deficit/hyperactivity disorder on the patient and family: results from a European survey. Child Adolesc Psychiatry Ment Health 28 2 (2008) 31
34. Buitelaar J.K., Wilens T.E., Zhang S., et al. Comparison of symptomatic versus functional changes in children and adolescents with ADHD during randomized, double-blind treatment with psychostimulants, atomoxetine, or placebo. J Child Psychol Psychiatry 50 (2009) 335-342
35. Rosenberg M. Society and the Adolescent Self-Image (1965), Princeton University Press, Princeton, NJ
36. Becker K., Wehmeier P.M., and Schmidt M.H. The Noradrenergic Transmitter System in ADHD. Principles and Implications for Treatment (2006), Thieme, Stuttgart, Germany
37. Klimkeit I., Graham C., Lee P., et al. Children should be seen and heard. Self-report of feelings and behavior in primary-school-age children with ADHD. J Atten Disord 10 (2006) 181-191
38. Fischer M., Barkley R.A., Edelbrock C.S., et al. The adolescent outcome of hyperactive children diagnosed by research criteria: II. Academic, attentional, and neuropsychological status. J Consult Clin Psychol 58 (1990) 580-588
39. Pfiffner L.J., McBurnett K., Lahery B.B., et al. Association of parental psychopathology to the comorbid disorders of boys with attention-deficit hyperactivity disorder. J Consult Clin Psychol 67 (1999) 881-893
40. Wilens T.E., Biederman J., Brown S., et al. Psychiatric comorbidity and functioning in clinically-referred preschool. children and school-age youth with ADHD. J Am Acad Child Adolesc Psychiatry 41 (2002) 262-268
41. Kuhne M., Schachar R., and Tannock R. Impact of comorbid oppositional or conduct problems on attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 36 (1997) 1715-1725
42. Schreyer I., and Hampel P. [ADHD among boys in childhood: quality of life and parenting behavior][Article in German]. Z Kinder Jugendpsychiatr Psychother 37 (2009) 69-75
43. Söderlund G., Sikström S., and Smart A. Listen to the noise: Noise is beneficial for cognitive performance in ADHD. J Child Psychol Psychiatry 48 (2007) 840-847
44. Coghill D., Spiel G., Baldursson G., et al. Which factors impact on clinician-rated impairment in children with ADHD?. Eur Child Adolesc Psychiatry 15 Suppl 1 (2006) i307
45. Becker A., Steinhausen H.C., Baldursson G., et al. Psychopathological screening of children with ADHD: Strengths and Difficulties Questionnaire in a pan-European study. Eur Child Adolesc Psychiatry 15 Suppl 1 (2006) i56-i62
46. Meltzer H., Gatward R., Goodman R., et al. Mental health of children and adolescents in Great Britain. Int Rev Psychiatry 15 (2003) 185-187
47. Hoza B., Mrug S., Gerdes A.C., et al. What aspects of peer relationships are impaired in children with attention-deficit/hyperactivity disorder?. J Consult Clin Psychol 73 (2005) 411-423
48. King C.A., and Young R.D. Peer popularity and peer communication patterns: hyperactive versus active but normal boys. J Abnorm Child Psychol 9 (1981) 465-482
49. Gresham F.M., MacMillan D.L., Bocian K.M., et al. Comorbidity of hyperactivity-impulsivity-inattention and conduct problems: Risk factors in social, affective, and academic domains. J Abnorm Child Psychol 26 (1998) 393-406
50. Braaten E.B., and Rosén L.A. Self-regulation of affect in attention-deficit hyperactivity disorder (ADHD) and non-ADHD boys: Differences in empathic responding. J Consult Clin Psychol 68 (2000) 313-321
51. Melnick S.M., and Hinshaw S.P. Emotion regulation and parenting in AD/HD and comparison boys: Linkages with social behaviors and peer preference. J Abnorm Child Psychol 28 (2000) 73-86
52. Treuting J.J., and Hinshaw S.P. Depression and self-esteem in boys with attention-deficit/hyperactivity disorder: Associations with comorbid aggression and explanatory attributional mechanisms. J Abnorm Child Psychol 29 (2001) 23-39
53. Hechtman L., Weiss G., and Perlman T. Hyperactives as young adults: self-esteem and social skills. Can J Psychiatry 25 (1980) 478-483
54. Alston C.Y., and Romney D.M. A comparison of medicated and nonmedicated attention-deficit disordered hyperactive boys. Acta Paedopsychiatr 55 (1992) 65-70
55. Edbom T., Lichtenstein P., Granlund M., et al. Long-term relationships between symptoms of attention deficit hyperactivity disorder and self-esteem in a prospective longitudinal study of twins. Acta Paediatrica 95 (2006) 650-657
56. Tafarodi R.W., and Swann W.B. Self-liking and self-competence as dimensions of global self-esteem: Initial validation of a measure. J Pers Assess 65 (1995) 322-342
57. Tafarodi R.W., and Swann W.B. Two-dimensionsal self-esteem: Theory and measurement. Pers Individ Dif 31 (2001) 653-673
58. Krueger M., and Kendall J. Descriptions of self: an exploratory study of adolescents with ADHD. J Child Adolesc Psychiatr Nurs 14 (2001) 61-72
59. Serretti A., Olgiati P., and Colombo C. Components of self-esteem in affective patients and non-psychiatric controls. J Affect Disord 88 (2005) 93-98
60. O'Dea J.A. Self-concept, self-esteem and body weight in adolescent females: A three-year longitudinal study. J Health Psychol 11 (2006) 599-611
61. Roy M.A., Neale M.C., and Kendler K.S. The genetic epidemiology of self-esteem. Br J Psychiatry 166 (1995) 813-820
62. Raevuori A., Dick D.M., Keski-Rahkonen A., et al. Genetic and environmental factors affecting self-esteem from age 14 to 17: A longitudinal study of Finnish twins. Psychol Med 37 (2007) 1625-1633
63. Steinhausen H.C., Metzke C.W., Meier M., et al. Prevalence of child and adolescent psychiatric disorders: The Zurich Epidemiological Study. Acta Psychiatra Scand 98 (1998) 262-271
64. Angold A., Costello E.J., and Erkanli A. Comorbidity. J Child Psychol Psychiatry 40 (1999) 57-87
65. Kadesjo B., and Gillberg C. The comorbidity of ADHD in the general population of Swedish school-age children. J Child Psychol Psychiatry 42 (2001) 487-492
66. Jensen P.S., Hinshaw S.P., Kraemer H.C., et al. ADHD comorbidity findings from the MTA study: Comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry 40 (2001) 147-158
67. Connor D., Edwards G., Fletcher K.E., et al. Correlates of comorbid psychopathology in children with ADHD. J Am Acad Child Adolesc Psychiatry 42 (2003) 193-200
68. Steinhausen H.C., Nøvik T.S., Baldursson G., et al. Co-existing psychiatric problems in ADHD in the ADORE cohort. Eur Child Adolesc Psychiatry 15 Suppl 1 (2006) i25-i29
69. Elia J., Ambrosini P., and Berrettini W. ADHD characteristics: I. Concurrent co-morbidity patterns in children and adolescents. Child Adolesc Psychiatry Ment Health 2 (2008) 15
70. Gioia G.A., Isquith P.K., Guy S.C., et al. BRIEF: Behavior Rating Inventory of Executive Function (2000), Psychological Assessment Resources, Inc, Odessa, FL
71. Lynam D.R. Early identification of the fledgling psychopath: Locating the psychopathic child in the current nomenclature. J Abnorm Psychology 107 (1998) 566-575
72. Waschbusch D.A. A meta-analytic examination of comorbid hyperactive-impulsive-attention problems and conduct problems. Psychological Bull 128 (2002) 118-150
73. Hoy E., Weiss G., Minde K., et al. The hyperactive child at adolescence: cognitive, emotional and social functioning. J Abnorm Child Psychol 6 (1978) 311-324
74. Biederman J., Faraone S., Milberger S., et al. A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Arch Gen Psychiatry 5 (1996) 437-446
75. Ingram S., Hechtman L., and Morgenstern G. Outcome issues in ADHD: Adolescent and adult long-term outcome. Ment Retard Dev Rehabil Res Rev 5 (1999) 243-250
76. Milich R., and Loney J. The role of hyperactivity and aggressive symptomatology in predicting adolescent outcome among hyperactive children. J Pediatr Psychol 4 (1979) 93-112
77. Rubia K., Noorloos J., Smith A., et al. Motor timing deficits in community and clinical boys with hyperactive behavior: the effect of methylphenidate on motor timing. J Abnorm Child Psychol 31 (2003) 301-313
78. Rubia K., Smith A.B., Halari R., et al. Disorder-specific dissociation of orbitofrontal dysfunction in boys with pure conduct disorder during reward and ventrolateral prefrontal dysfunction in boys with pure ADHD during sustained attention. Am J Psychiatry 166 (2009) 83-94
79. Coghill D., Danckaerts M., Sonuga-Barke E., et al. Practitioner review: quality of life in child mental health - Conceptual challenges and practical choices. J Child Psychol Psychiatry 50 (2009) 544-561
80. Wallander J.L., Schmitt M., and Koot H.M. Quality of life measurements in children and adolescents: Issues, instruments, and applications. J Clin Psychol 57 (2001) 571-585
81. Danckaerts M., Sonuga-Barke E.J., Banaschewski T., et al. The quality of life of children with attention deficit/hyperactivity disorder: A systematic review. Eur Child Adolesc Psychiatry (2009) [Epub ahead of print]
82. Leidy N.K., Revicki D.A., and Geneste B. Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health 2 (1999) 113-127
83. Revicki D.A., Osoba D., Fairclough D., et al. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res 9 (2000) 887-900
84. Landgraf J.M., Abetz L.N., and Ware J.E. The CHQ Users Manual (1999), Health Act, Boston, MA
85. Varni J.W., Seid M., and Kurtin P.S. PedsQL 4.0: Reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care 39 (2001) 800-812
86. Riley A.W., Forrest C.B., Rebok G.W., et al. The Child Report Form of the CHIP-Child Edition: Reliability and validity. Med Care 42 (2004) 221-231
87. Riley A.W., Forrest C.B., Starfield B., et al. The Parent Report Form of the CHIP-Child Edition: Reliability and validity. Med Care 42 (2004) 210-220
88. Ravens-Sieberer U., Auquier P., Erhart M., et al. The KIDSCREEN-27 quality of life measure for children and adolescents: Psychometric results from a cross-cultural survey in 13 European countries. Qual Life Res 16 (2007) 1347-1356
89. World Health Organization. International Classification of Functioning, Disability and Health (2001), WHO, Geneva, Switzerland
90. Üstün T.B. Using the international classification of functioning, disease and health in attention-deficit/hyperactivity disorder: Separating the disease from its epiphenomena. Ambul Pediatr 7 Suppl 1 (2007) 132-139
91. Topolski T.D., Edwards T.C., Patrick D.L., et al. Quality of life of adolescent males with attention-deficit hyperactivity disorder. J Atten Disord 7 (2004) 163-173
92. Hampel P., and Desman C. Stressverarbeitung und Lebensqualität bei Kindern und Jugendlichen mit Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung. Prax Kinderpsychol Kinderpsychiatr 55 (2006) 425-443
93. Hechtman A., Abikoff H., Klein R.G., et al. Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry 43 (2004) 812-819
94. Brown R.T., Perwien A., Faries D.E., et al. Atomoxetine in the management of children with ADHD: Effects on quality of life and school functioning. Clin Pediatr (Phila) 45 (2006) 819-827
95. Matza L.S., Stoeckl M.N., Shorr J.M., et al. Impact of atomoxetine on health-related quality of life and functional status in patients with ADHD. Expert Rev Pharmacoecon Outcomes Res 6 (2006) 379-390
96. Yang P., Hsu H.Y., Chiou S.S., et al. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: Results from a Taiwanese sample. Aust N Z J Psychiatry 41 (2007) 998-1004
97. Prasad S., Harpin V., Poole L., et al. A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Curr Med Res Opin 23 (2007) 379-394
98. Wehmeier P.M., Dittmann R.W., Schacht A., et al. Effectiveness of atomoxetine in children with attention-deficit/hyperactivity disorder and quality of life as perceived by patients, parents and physicians in an open-label study. J Child Adolesc Psychopharmacol 17 (2007) 813-830
99. Bastiaens L. Both atomoxetine and stimulants improve quality of life in an ADHD population treated in a community clinic. Psychiatr Q 79 (2008) 133-137
100. Hinshaw S.P. Impulsivity, emotion regulation, and developmental psychopathology: Specificity versus generality of linkages. Ann N Y Acad Sci 1008 (2003) 149-159
101. Ochsner K.N., and Gross J.J. The cognitive control of emotion. Trends Cogn Sciences 9 (2005) 242-249
102. Etkin A., Egner T., Peraza D.M., et al. Resolving emotional conflict: a role for the rostral anterior cingulate cortex in modulating activity in the amygdala. Neuron 51 (2006) 871-882
103. Berger A., Kofman O., Livneh U., et al. Multidisciplinary perspectives on attention and the development of self-regulation. Prog Neurobiol 82 (2007) 256-286
104. Barkley R.A. Adolescents with attention-deficit/hyperactivity disorder: An overview of empirically based treatments. J Psychiatr Pract 10 (2004) 39-56
105. Antshel K.M., and Barkley R. Psychosocial interventions in attention deficit hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 17 (2008) 421-437
106. Taylor E., Sergeant J., Döpfner M., et al. Clinical guidelines for hyperkinetic disorder. European Child Adolesc Psychiatry 7 (1998) 184-200
107. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 56 (1999) 1073-1086
108. MTA Cooperative Group. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: The Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56 (1999) 1088-1096
109. Jensen P.S., Hinshaw S.P., Swanson J.M., et al. Findings from the NIMH multimodal treatment study of ADHD (MTA): Implications and applications for primary care providers. J Dev Behav Pediatr 22 (2001) 60-73
110. Evans S.W., Pelham W.E., Smith B.H., et al. Dose-response effects of methylphenidate on ecologically valid measures of academic performance and classroom behavior in adolescents with ADHD. Exp Clin Psychopharmacol 9 (2001) 163-175
111. Smith B.H., Waschbusch D.A., Willoughby M.T., et al. The efficacy, safety, and practicality of treatments for adolescents with attention-deficit/hyperactivity disorder (ADHD). Clin Child Fam Psychol Rev 3 (2000) 243-267
112. Cheng J.Y., Chen R.Y., Ko J.S., et al. Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents. Meta-analysis and meta-regression analysis. Psychopharmacology (Berl) 194 (2007) 197-209
113. Wilens T.E., Kratochvil C., Newcorn J.H., et al. Do children and adolescents with ADHD respond differently to atomoxetine?. J Am Acad Child Adolesc Psychiatry 45 (2006) 149-157
114. Banaschewski T., Coghill D., Santosh P., et al. Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guidelines. Eur Child Adolesc Psychiatry 15 (2006) 476-495
115. Wehmeier P.M., Schacht A., Lehmann M., et al. Emotional well-being in children and adolescents treated with atomoxetine for attention-deficit/hyperactivity disorder: Findings from a patient, parent and physician perspective. Child Adolesc Psychiatry Ment Health 2 (2008) 10
116. Flapper B.C., and Schoemaker M.M. Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD. Dev Med Child Neurol 50 (2008) 294-299
117. Escobar R., Montoya A., Polavieja P., et al. Evaluation of patients' and parents' quality of life in a randomized placebo-controlled atomoxetine study in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 19 (2009) 253-263
118. Spencer T.J., Abikoff H.B., Connor D.F., et al. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study. Clin Ther 28 (2006) 402-418
119. Spencer T.J., Landgraf J.M., Adler L.A., et al. Attention-deficit/hyperactivity disorder-specific quality of life with triple-bead mixed amphetamine salts (SPD465) in adults: Results of a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 69 (2008) 1766-1775
120. Swanson J.M., Wigal S.B., Wigal T., et al. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study). Pediatrics 113 3 Pt 1 (2004) e206-e216
121. Buitelaar J.K., Michelson D., Danckaerts M., et al. A randomized, double-blind study of continuation treatment for attention-deficit/hyperactivity disorder after 1 year. Biol Psychiatry 61 (2007) 694-699
122. Swanson J., Arnold L.E., Kraemer H., et al. Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: Supporting details. J Atten Disord 12 1 (2008) 15-43
123. Swanson J., Arnold L.E., Kraemer H., et al. Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): Part I: Executive summary. J Atten Disord 12 1 (2008) 4-14
124. Wilens T.E., Newcorn J.H., Kratochvil C.J., et al. Long-term atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder. J Pediatr 149 (2006) 112-119